Why Diagnosing Anaerobic Vaginosis is a Challenge
In a bustling sexual health clinic in downtown London, a renowned gynaecologist peered into her microscope, squinting at the slide before her. Her 28-year-old patient sitting anxiously on the exam table had complained of recurrent vaginal discomfort and unusual discharge for months.
Despite multiple rounds of antibiotics, her symptoms kept returning. As the gynaecologist examined the vaginal swab sample, she let out a barely noticeable sigh in frustration. The microscopic view offered limited insights, leaving her uncertain about the true nature of her patient’s condition.
While the above story is entirely fictional, something eerily similar plays out in sexual health clinics and gynaecologist practices across the country every single day, highlighting one of the most significant challenges in women’s health: accurately diagnosing anaerobic bacteria and other vaginal microbiome imbalances.
While traditional diagnostic methods like microscopy have been the standard for decades, they often fall short in capturing the full complexity of the vaginal microbiome. However, a revolution in diagnostic technology is on the horizon, promising to transform how we understand and treat these common – yet often misdiagnosed – conditions.
Table of Contents:
The Limitations of Traditional Vaginal Culture Diagnostics
Identifying Anaerobic Bacteria with NGS Vaginal Microbiome Analytics
The Real-World Impact of NGS-Based Vaginal Microbiome Analytics
The Challenges & Future of Shotgun-NGS Vaginal Microbiome Analytics
The Limitations of Traditional Vaginal Diagnostics
For years, clinicians and sexual health professionals have relied on a combination of physical examination, pH testing, and microscopic analysis of vaginal fluid samples to diagnose conditions like bacterial vaginosis (BV).
These methods, while accessible and relatively inexpensive, have significant drawbacks:
- Limited view of microbial diversity: Microscopy can only detect a fraction of the microorganisms present in the vaginal environment. But many anaerobic bacteria associated with dysbiosis are difficult to identify through traditional means.
- Subjective interpretation: The accuracy of microscopic analysis depends heavily on the skill and experience of the individual examining the sample. This can often lead to inconsistent diagnoses between practitioners, making patients sceptical of their doctors’ judgements.
- Inability to detect subtle imbalances: Early stages of dysbiosis or more nuanced shifts in the vaginal microbiome may not be apparent through standard microscopic examination. This makes early detection and treatment challenging – and patients often only get the treatment they need after prolonged periods of suffering.
- Lack of species-level identification: While microscopy can broadly categorise bacteria (e.g. as gram-positive or gram-negative), it cannot provide detailed information about specific bacterial species and their relative abundances. Additionally, many anaerobic bacteria look similar under the microscope, giving way to human errors in distinguishing them from each other.
Or to put it in simpler terms: Imagine trying to understand an entire forest by cataloguing only some of the trees visible from one path…
Well, that’s what trying to study the vaginal microbiome using traditional methods is like – at least according to Dr Martin J. Blaser, the director of the Centre for Advanced Biotechnology and Medicine at Rutgers (NJ) Biomedical and Health.
Identifying Anaerobic Bacteria with NGS Vaginal Microbiome Analytics
Next-generation sequencing (NGS) technologies such as Shotgun-NGS have the potential to transform how sexual health professionals understand and identify a wide range of vaginal infections.
This powerful molecular diagnostic tool allows researchers and clinicians alike to analyse the genetic material of entire microbial communities, providing an unprecedented level of detail about the composition and functions of the vaginal microbiome.
When it comes to identifying anaerobic bacteria, supplementing traditional diagnostic methods with shotgun NGS-based microbiome analytics offers several key advantages:
- Comprehensive microbial profiling: Shotgun-NGS can detect and identify virtually all microorganisms present in a sample at the species level – including those that are difficult or impossible to culture – with over 99.99% accuracy.
- Quantitative analysis: Beyond simply identifying which microbes are present, shotgun-NGS can provide information about their relative abundances, offering a more nuanced picture of the microbial community structure.
- Functional insights: By analysing microbial genes, shotgun-NGS has the potential to offer clues about the metabolic activities and potential pathogenicity of different microorganisms within the vaginal environment.
- Standardisation and reproducibility: shotgun-NGS-based methods are highly standardised and automated, reducing the potential for human error and subjective interpretation.
- Detection of emerging pathogens: shotgun-NGS can identify novel or previously uncharacterised microorganisms that may be associated with vaginal dysbiosis or other health issues.
Therefore, vaginal microbiome tests using “shotgun” NGS technology allow researchers to see the vaginal microbiome in high definition. This means that we’re not just counting bacteria anymore; we’re understanding entire microbial ecosystems and how they interact with the host.*While it is true that there are various competing next-generation sequencing technologies – such as 16S rRNA sequencing – shotgun-NGS is widely considered the most advanced and useful for informing health & wellness decisions. Find out why here!
The Real-World Impact of NGS-Based Vaginal Microbiome Analytics
The adoption of shotgun-NGS-based microbiome analytics in clinical settings is already beginning to change the landscape of women’s health. Companies like BiomEdge are helping gynaecologists, sexual health professionals, and other health & wellness practitioners implement shotgun-NGS microbiome analytics into their daily practice – and it’s starting to have an impact already!
Consider the case of Emma, for example: a 35-year-old woman from Leeds, who had struggled with recurrent vaginal symptoms for years. Despite multiple visits to her gynaecologist and rounds of antibiotic treatment, her problems persisted.
“I felt like I was going crazy” – Emma recalls – “Every test came back normal, but I knew something wasn’t right.”
When Emma’s gynaecologist suggested a “shotgun” NGS-based microbiome test, the results were revelatory. The analysis revealed a complex dysbiosis involving multiple anaerobic bacterial species that had gone undetected by traditional methods. Armed with this detailed information, Emma’s healthcare team was able to develop a targeted treatment plan that finally brought her relief.
And Emma’s results are quite typical: since “shotgun” next-generation sequencing gives us the ability to move beyond broad diagnoses like ‘bacterial vaginosis’ and really understand the unique microbial signature of each patient, it also opens the door to more personalised and effective treatments.
The Challenges & Future of Shotgun-NGS Vaginal Microbiome Analytics
While the potential of shotgun-NGS microbiome analytics is immense, there are still hurdles to overcome before it becomes a standard part of clinical care:
- Cost and accessibility: Shotgun-NGS technology remains relatively expensive and is not yet widely available in all clinical settings. Although companies like BiomEdge are paving the way for widespread adoption, some patients will always prefer lower-cost technologies – even if those come with other drawbacks.
- Clinical guidelines: There is a need for standardised guidelines on how to translate NGS results into actionable clinical decisions. Despite BiomEdge offering its partners training and continuous support, incorporating NGS-based diagnostics into established clinical workflows will require education, adaptation, and effort from health & wellness practitioners.
Despite these challenges, the future looks bright. As technology continues to advance and costs decrease, NGS-based microbiome analytics are poised to become an integral part of women’s health care. This, in turn, opens the door to new therapeutic approaches, including targeted probiotics and personalised treatment regimens based on an individual’s unique microbial profile.
A New Era in Vaginal Health
As we stand on the brink of this diagnostic revolution, it’s clear that NGS-based microbiome analytics have the potential to fundamentally change how we approach vaginal health.
By providing a more comprehensive and nuanced understanding of the vaginal microbiome, this technology can supplement existing diagnostic methods to empower clinicians to make more informed decisions – offering hope to millions of women who have struggled with persistent and often misdiagnosed vaginal health issues.
After all, with NGS, we’re not just treating symptoms; we’re helping to address the root causes of vaginal dysbiosis and promoting true vaginal health. And one day – hopefully soon – every woman will be able to benefit from this level of personalised care.
As research continues and technology advances, the integration of NGS-based microbiome analytics into routine clinical care may soon transform this hope into reality, ushering in a new era of precision medicine in women’s health.


Comments are closed